These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20681944)

  • 1. Adenosine receptor ligands: where are we, and where are we going?
    Tuccinardi T; Martinelli A
    Curr Top Med Chem; 2010; 10(10):941. PubMed ID: 20681944
    [No Abstract]   [Full Text] [Related]  

  • 2. Ribose modified nucleosides and nucleotides as ligands for purine receptors.
    Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments in adenosine receptor ligands and their potential as novel drugs.
    Müller CE; Jacobson KA
    Biochim Biophys Acta; 2011 May; 1808(5):1290-308. PubMed ID: 21185259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescent ligands for adenosine receptors.
    Kozma E; Jayasekara PS; Squarcialupi L; Paoletta S; Moro S; Federico S; Spalluto G; Jacobson KA
    Bioorg Med Chem Lett; 2013 Jan; 23(1):26-36. PubMed ID: 23200243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature.
    Sousa JB; Fresco P; Diniz C; Goncalves J
    Recent Pat Anticancer Drug Discov; 2018; 13(1):40-69. PubMed ID: 29119938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and purine receptor affinity of 6-oxopurine nucleosides and nucleotides containing (N)-methanocarba-pseudoribose rings.
    Ravi G; Lee K; Ji X; Kim HS; Soltysiak KA; Marquez VE; Jacobson KA
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2295-300. PubMed ID: 11527718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in the Development of Agonists, Antagonists and Allosteric Modulators of Adenosine Receptors.
    Deb PK
    Curr Pharm Des; 2019; 25(25):2695-2696. PubMed ID: 31603053
    [No Abstract]   [Full Text] [Related]  

  • 8. Theoretical structure-activity studies of adenosine A1 ligands: requirements for receptor affinity.
    Dooley MJ; Kono M; Suzuki F
    Bioorg Med Chem; 1996 Jun; 4(6):923-34. PubMed ID: 8818243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicinal chemistry of adenosine A1 receptor ligands.
    Soudijn W; van Wijngaarden I; IJzerman AP
    Curr Top Med Chem; 2003; 3(4):355-67. PubMed ID: 12570755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expeditious synthesis and biological evaluation of new C-6 1,2,3-triazole adenosine derivatives A1 receptor antagonists or agonists.
    Mathew SC; By Y; Berthault A; Virolleaud MA; Carrega L; Chouraqui G; Commeiras L; Condo J; Attolini M; Gaudel-Siri A; Ruf J; Rodriguez J; Parrain JL; Guieu R
    Org Biomol Chem; 2010 Sep; 8(17):3874-81. PubMed ID: 20617271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of adenosine receptor agonists and antagonists on transport of adenosine in bovine heart microvascular endothelial cells.
    Barankiewicz J
    Adv Exp Med Biol; 2000; 486():227-31. PubMed ID: 11783489
    [No Abstract]   [Full Text] [Related]  

  • 12. Ring-Constrained (N)-methanocarba nucleosides as adenosine receptor agonists: independent 5'-uronamide and 2'-deoxy modifications.
    Lee K; Ravi G; Ji XD; Marquez VE; Jacobson KA
    Bioorg Med Chem Lett; 2001 May; 11(10):1333-7. PubMed ID: 11392549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A(3) adenosine receptor ligands: history and perspectives.
    Baraldi PG; Cacciari B; Romagnoli R; Merighi S; Varani K; Borea PA; Spalluto G
    Med Res Rev; 2000 Mar; 20(2):103-28. PubMed ID: 10723024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity.
    Betti M; Catarzi D; Varano F; Falsini M; Varani K; Vincenzi F; Pasquini S; di Cesare Mannelli L; Ghelardini C; Lucarini E; Dal Ben D; Spinaci A; Bartolucci G; Menicatti M; Colotta V
    J Med Chem; 2019 Aug; 62(15):6894-6912. PubMed ID: 31306001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological modulation of adenosine receptor pathways and inflammatory disorders: the way towards novel therapeutics?
    Antonioli L; Fornai M; Colucci R; Tuccori M; Blandizzi C
    Expert Opin Investig Drugs; 2011 Jun; 20(6):717-21. PubMed ID: 21506907
    [No Abstract]   [Full Text] [Related]  

  • 16. Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).
    Jacobson KA
    Bioconjug Chem; 2009 Oct; 20(10):1816-35. PubMed ID: 19405524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Updates in the Computer Aided Drug Design Strategies for the Discovery of Agonists and Antagonists of Adenosine Receptors.
    Deb PK
    Curr Pharm Des; 2019; 25(7):747-749. PubMed ID: 31232230
    [No Abstract]   [Full Text] [Related]  

  • 18. Allosteric modulators for adenosine receptors: an alternative to the orthosteric ligands.
    La Motta C; Sartini S; Morelli M; Taliani S; Da Settimo F
    Curr Top Med Chem; 2010; 10(10):976-92. PubMed ID: 20370657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A1 adenosine receptors and their ligands: overview and recent developments.
    Müller CE
    Farmaco; 2001; 56(1-2):77-80. PubMed ID: 11347971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of adenosine receptor ligands in medical imaging by positron emission tomography.
    Holschbach MH; Olsson RA
    Curr Pharm Des; 2002; 8(26):2345-52. PubMed ID: 12369949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.